Attitudes towards coronavirus (COVID-19) vaccine and sources of information across diverse ethnic groups in the UK: a qualitative study from June to October 2020.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
01 09 2022
Historique:
entrez: 29 12 2022
pubmed: 30 12 2022
medline: 3 1 2023
Statut: epublish

Résumé

Across diverse ethnic groups in the UK, explore attitudes and intentions towards COVID-19 vaccination and sources of COVID-19 information. Remote qualitative interviews and focus groups (FGs) conducted June-October 2020 before UK COVID-19 vaccine approval. Data were transcribed and analysed through inductive thematic analysis and mapped to the Theoretical Domains Framework. England and Wales. 100 participants from 19 self-identified ethnic groups. Mistrust and doubt were reported across ethnic groups. Many participants shared concerns about perceived lack of information about COVID-19 vaccine safety and efficacy. There were differences within each ethnic group, with factors such as occupation and perceived health status influencing intention to accept a vaccine once made available. Across ethnic groups, participants believed that public contact occupations, older adults and vulnerable groups should be prioritised for vaccination. Perceived risk, social influences, occupation, age, comorbidities and engagement with healthcare influenced participants' intentions to accept vaccination once available. All Jewish FG participants intended to accept, while all Traveller FG participants indicated they probably would not.Facilitators to COVID-19 vaccine uptake across ethnic groups included: desire to return to normality and protect health and well-being; perceived higher risk of infection; evidence of vaccine safety and efficacy; vaccine availability and accessibility.COVID-19 information sources were influenced by social factors and included: friends and family; media and news outlets; research literature; and culture and religion. Participants across most different ethnic groups were concerned about misinformation or had negative attitudes towards the media. During vaccination rollout, including boosters, commissioners and providers should provide accurate information, authentic community outreach and use appropriate channels to disseminate information and counter misinformation. Adopting a context-specific approach to vaccine resources, interventions and policies and empowering communities has potential to increase trust in the programme.

Identifiants

pubmed: 36581971
pii: bmjopen-2022-060992
doi: 10.1136/bmjopen-2022-060992
pmc: PMC9437733
doi:

Substances chimiques

COVID-19 Vaccines 0
Vaccines 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e060992

Informations de copyright

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: AKamal participates in the UK’s Scientific Advisory Group for Emergencies (SAGE) behavioural science subgroup SPI-B. LFJ and CM have been involved in the review of Public Health England/UK Health Security Agency COVID-19 guidance. All other authors have no conflicts of interest to declare.

Références

Pediatrics. 2008 Oct;122(4):718-25
pubmed: 18829793
Acad Emerg Med. 2020 Jul;27(7):640-641
pubmed: 32474977
Lancet Glob Health. 2020 Aug;8(8):e1003-e1017
pubmed: 32553130
Vaccines (Basel). 2021 Oct 01;9(10):
pubmed: 34696228
J Migr Health. 2021;4:100050
pubmed: 34075367
J Public Health (Oxf). 2022 Apr 04;:
pubmed: 35373295
Econ Lett. 2021 Mar;200:109747
pubmed: 33551522
Midwifery. 2021 Sep;100:103062
pubmed: 34198208
Vaccines (Basel). 2020 Oct 03;8(4):
pubmed: 33022907
Science. 2003 Aug 8;301(5634):804
pubmed: 12907792
Vaccines (Basel). 2021 May 02;9(5):
pubmed: 34063182
PLoS One. 2021 Feb 19;16(2):e0246941
pubmed: 33606782
Nat Hum Behav. 2021 Jul;5(7):960
pubmed: 34239082
SSM Qual Res Health. 2022 Dec;2:100035
pubmed: 35013736
Hum Vaccin Immunother. 2014;10(9):2543-50
pubmed: 25483472
PLoS One. 2021 May 12;16(5):e0251605
pubmed: 33979412
Hum Vaccin Immunother. 2021 Jun 3;17(6):1612-1621
pubmed: 33242386
Am J Trop Med Hyg. 2020 Aug;103(2):920-921
pubmed: 32534600
J Med Internet Res. 2020 Apr 05;:
pubmed: 32250961
J Epidemiol Community Health. 2022 Jul;76(7):646-652
pubmed: 35470259
Lancet Reg Health Eur. 2021 Oct;9:100180
pubmed: 34308406
Isr J Health Policy Res. 2021 Mar 19;10(1):26
pubmed: 33741063
Vaccine. 2021 Feb 12;39(7):1080-1086
pubmed: 33461833
Ethn Health. 2022 Oct;27(7):1555-1574
pubmed: 34092149
J Med Internet Res. 2020 Nov 13;22(11):e22205
pubmed: 33048825
Patient. 2021 May;14(3):309-318
pubmed: 33783724
Vaccine. 2015 Aug 14;33(34):4180-90
pubmed: 25896377
Vaccines (Basel). 2020 Aug 27;8(3):
pubmed: 32867126
J Adolesc Health. 2021 May;68(5):869-872
pubmed: 33824070
Lancet. 2021 May 8;397(10286):1725-1735
pubmed: 33901423
BMJ Open. 2022 Mar 1;12(3):e055278
pubmed: 35232787
BMJ Open. 2022 Aug 17;12(8):e061027
pubmed: 35977758
Implement Sci. 2017 Jun 21;12(1):77
pubmed: 28637486
Lancet Reg Health Eur. 2021 Feb;1:100012
pubmed: 33954296
BMC Public Health. 2021 Apr 28;21(1):817
pubmed: 33910548
BMJ Open. 2022 Mar 18;12(3):e053827
pubmed: 35304394
Br J Gen Pract. 2021 Dec 31;72(714):e51-e62
pubmed: 34750106
Vaccine. 2007 Nov 7;25(45):7818-23
pubmed: 17920170
Vaccine. 2018 Oct 22;36(44):6556-6558
pubmed: 28830694
Vaccine. 2020 Nov 17;38(49):7789-7798
pubmed: 33109389

Auteurs

Eirwen Sides (E)

Primary Care and Interventions Unit, UKHSA South West, Bristol, UK Eirwen.Sides@ukhsa.gov.uk.

Leah Ffion Jones (LF)

Primary Care and Interventions Unit, UKHSA South West, Bristol, UK.

Atiya Kamal (A)

Psychology, Birmingham City University, Birmingham, UK.

Amy Thomas (A)

Primary Care and Interventions Unit, UKHSA South West, Bristol, UK.

Rowshonara Syeda (R)

Prevention Strategy & Innovation Team, UK Department of Health and Social Care, London, UK.

Awatif Kaissi (A)

Primary Care and Interventions Unit, UKHSA South West, Bristol, UK.

Donna M Lecky (DM)

Primary Care and Interventions Unit, UKHSA South West, Bristol, UK.

Mahendra Patel (M)

School of Pharmacy and Medical Sciences (Faculty of Life Sciences), University of Bradford, Bradford, UK.

Laura Nellums (L)

Faculty of Medicine & Health Sciences, University of Nottingham, Nottingham, UK.

Jane Greenway (J)

UKHSA South West, Bristol, UK.

Ines Campos-Matos (I)

Migration Health, Health Improvement Directorate, UKHSA, London, UK.

Rashmi Shukla (R)

Regions and Places, UKHSA, London, UK.

Colin S Brown (CS)

Bacteria Reference Department, National Infection Service, UKHSA, London, UK.

Manish Pareek (M)

Department of Respiratory Sciences, University of Leicester, Leicester, UK.

Loretta Sollars (L)

UK Department of Health and Social Care, London, UK.

Emma Pawson (E)

UK Department of Health and Social Care, London, UK.

Cliodna McNulty (C)

Primary Care and Interventions Unit, UKHSA South West, Bristol, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH